ABVC BioPharma, Inc.

ECOC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
D May 28, 2024
8-K May 24, 2024 CURRENT REPORT
8-K May 23, 2024 CURRENT REPORT
424B4 May 23, 2024 PROSPECTUS SUPPLEMENT
424B4 May 22, 2024 PROSPECTUS
424B4 May 22, 2024 PROSPECTUS SUPPLEMENT
8-K/A May 17, 2024 FORM 8-K/A
10-Q May 17, 2024 QUARTERLY REPORT
NT 10-Q May 15, 2024 NOTIFICATION OF LATE FILING
8-K May 15, 2024 CURRENT REPORT
8-K May 9, 2024 CURRENT REPORT
EFFECT Apr 30, 2024
PRE 14A Apr 26, 2024 PRELIMINARY PROXY STATEMENT
POS AM Apr 25, 2024 POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1
8-K Apr 19, 2024 FORM 8-K
8-K Apr 17, 2024 CURRENT REPORT
424B4 Apr 5, 2024 PROSPECTUS
EFFECT Apr 1, 2024
CORRESP Mar 29, 2024
8-K Mar 26, 2024 CURRENT REPORT
DEFA14A Mar 25, 2024 DEFINITIVE ADDITIONAL MATERIALS
S-1/A Mar 22, 2024 AMENDMENT NO. 3 TO FORM S-1
10-K/A Mar 15, 2024 AMENDMENT NO. 1 TO FORM 10-K
DEFA14A Mar 14, 2024 DEFINITIVE ADDITIONAL MATERIALS
8-K Mar 14, 2024 FORM 8-K
← Newer Page 5 of 32 · 793 filings Older →